Skip to main content
. 2022 Apr 12;13(4):9264–9273. doi: 10.1080/21655979.2022.2036904

Figure 1.

Figure 1.

The expression of OIP5-AS1 and PD-L1 in NSCLC. The expression levels of OIP5-AS1 mRNA (a) and PD-L1 mRNA (b) were both elevated in NSCLC tumor and non-tumor samples. *, p < 0.05. IHC was used to detect PD-L1 protein in 5 pairs of NSCLC tumor tissues and non-tumor tissues from 5 patients (c). In all 5 cases, the expression of PD-L1 protein was much stronger in NSCLC tumors compared to that in normal non-tumor tissues.